Balchem Corporation (BCPC)
Stock Price Chart
Key Info
| Market Cap | 3.33B |
| Revenue (ttm) | 672.91M |
| Net Income (ttm) | 81.95M |
| Shares Out | 32.35M |
| EPS (ttm) | 2.52 |
| PE Ratio | 40.81 |
| Forward PE | 36.23 |
| Dividend | $0.52 |
| Dividend Yield | 0.51% |
Stock Quote
| Trading Day | Aug 11, 2020 |
| Last Price | $102.83 |
| Previous Close | $102.82 |
| Change ($) | 0.01 |
| Change (%) | 0.01% |
| Day's Open | 103.86 |
| Day's Range | 102.34 - 104.47 |
| Day's Volume | 96,380 |
| 52-Week Range | 78.30 - 113.93 |
More Stats
| Market Cap | 3.33B |
| Enterprise Value | 3.47B |
| Earnings Date (est) | Nov 10, 2020 |
| Ex-Dividend Date | n/a |
| Shares Outstanding | 32.35M |
| Float | 32.10M |
| EPS (basic) | 2.56 |
| EPS (diluted) | 2.52 |
| FCF / Share | 3.59 |
| Dividend | $0.52 |
| Dividend Yield | 0.51% |
| Earnings Yield | 2.45% |
| FCF Yield | 3.48% |
| Payout Ratio | n/a |
| Shares Short | 494,519 |
| Short Ratio | 2.80 |
| Short % of Float | 1.83% |
| Beta | 0.62 |
| PE Ratio | 40.81 |
| Forward PE | 36.23 |
| P/FCF Ratio | 28.71 |
| PS Ratio | 4.94 |
| PB Ratio | 4.22 |
| Revenue | 672.91M |
| Operating Income | 102.87M |
| Net Income | 81.95M |
| Free Cash Flow | 115.86M |
| Net Cash | -148.02M |
| Net Cash / Share | -4.58 |
| Gross Margin | 31.41% |
| Operating Margin | 15.29% |
| Profit Margin | 12.20% |
| FCF Margin | 17.22% |
| ROA | 5.88% |
| ROE | 10.75% |
| ROIC | n/a |
Analyst Summary
Analyst Consensus: Overweight
Financial Performance
Financial Overview
| Year | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 644 | 644 | 595 | 553 | 552 | 541 | 337 | 310 | 292 | 255 |
| Revenue Growth | 0% | 8.22% | 7.52% | 0.13% | 2.05% | 60.57% | 8.63% | 6.35% | 14.43% | - |
| Gross Profit | 211 | 204 | 189 | 181 | 168 | 144 | 97.42 | 89.54 | 86.00 | 78.04 |
| Operating Income | 103 | 107 | 96.90 | 90.84 | 93.96 | 82.14 | 65.60 | 59.78 | 56.23 | 49.77 |
| Net Income | 79.67 | 78.57 | 90.07 | 55.97 | 59.72 | 52.83 | 44.87 | 40.01 | 38.77 | 33.28 |
| Shares Outstanding | 32.17 | 32.25 | 32.00 | 31.72 | 31.52 | 30.74 | 30.14 | 29.37 | 28.97 | 28.52 |
| Earnings Per Share | 2.45 | 2.42 | 2.79 | 1.75 | 1.89 | 1.69 | 1.45 | 1.32 | 1.28 | 1.12 |
| EPS Growth | 1.24% | -13.26% | 59.43% | -7.41% | 11.83% | 16.55% | 9.85% | 3.13% | 14.29% | - |
| Dividend Per Share | 0.52 | 0.47 | 0.42 | 0.38 | 0.34 | 0.30 | 0.26 | 0.22 | 0.18 | 0.15 |
| Dividend Growth | 10.64% | 11.9% | 10.53% | 11.76% | 13.33% | 15.38% | 18.18% | 22.22% | 20% | - |
| Operating Cash Flow | 124 | 119 | 111 | 108 | 104 | 85.35 | 55.69 | 53.78 | 44.90 | 39.03 |
| Capital Expenditures | -28.41 | -19.72 | -28.12 | -23.03 | -41.27 | -13.20 | -8.15 | -13.88 | -6.58 | -7.56 |
| Free Cash Flow | 96.05 | 98.97 | 82.50 | 84.58 | 62.56 | 72.15 | 47.55 | 39.90 | 38.32 | 31.47 |
| Cash & Equivalents | 65.67 | 54.27 | 40.42 | 38.64 | 84.80 | 50.29 | 209 | 145 | 115 | 77.25 |
| Total Debt | 256 | 156 | 219 | 280 | 296 | 333 | - | - | 1.41 | 4.91 |
| Net Cash / Debt | -190 | -102 | -179 | -242 | -211 | -282 | 209 | 145 | 113 | 72.34 |
| Assets | 1,156 | 981 | 964 | 949 | 880 | 862 | 377 | 313 | 272 | 229 |
| Liabilities | 412 | 290 | 347 | 428 | 416 | 470 | 45.51 | 39.53 | 39.71 | 41.16 |
| Book Value | 744 | 692 | 617 | 521 | 464 | 392 | 331 | 273 | 232 | 187 |
Company Profile
Company Details
| Full Name | Balchem Corporation |
| Country | United States |
| Employees | 1,424 |
| CEO | Theodore L. Harris |
Stock Information
| Ticker Symbol | BCPC |
| Stock Exchange | NASDAQ |
| Sector | Basic Materials |
| Industry | Chemicals - Major Diversified |
| Unique Identifier | NASDAQ: BCPC |
Description
Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the food, nutritional, feed, pharmaceutical, medical sterilization, and industrial markets in the United States and internationally. The company's Human Nutrition & Health segment supplies ingredients in the food and beverage industry. Its products include spray dried and emulsified powders, blended lipid systems, liquid flavor delivery systems, juice and dairy bases, chocolate systems, and cereal systems, as well as ice cream bases and variegates. This segment also offers microencapsulation solutions; and human grade choline nutrients and mineral amino acid chelated products for wellness applications. Its Animal Nutrition & Health segment provides microencapsulated products to enhance health and milk production in ruminant animals; chelation technology, which offers enhanced nutrient absorption for various species of production and companion animals; and choline chloride, a nutrient for monogastric animal health. The company's Specialty Products segment offers ethylene oxide primarily for use in the health care industry; and single use canisters with ethylene oxide for sterilizing re-usable devices. It also sells propylene oxide, a fumigant to aid in the control of insects and microbiological spoilage, as well as to reduce bacterial and mold contamination in shell and processed nut meats, processed spices, cacao beans, cocoa powder, raisins, figs, and prunes; and chelated minerals for high value crops. The company's Industrial Products segment provides choline chloride derivatives for hydraulic fracturing of shale natural gas wells; and methylamines, which are building blocks for the manufacture of choline products, as well as used in industrial applications. The company sells its products through sales force, independent distributors, and sales agents. Balchem Corporation was founded in 1967 and is headquartered in New Hampton, New York.